MEDICINOVA, INC. (MNOV) Current Ratio
- Current ratio · latest quarter: Value 8.75×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.75× | Current assets / current liabilities. $25.92M ÷ $2.96M ≈ 8.75× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 25.92M USD | Assets, Current |
| Current obligations | 2.96M USD | Liabilities, Current |
| Cash and equivalents | 25.42M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 0.00 USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 950.50K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.92M | $2.96M | $25.42M | (m) | $0.00 | (m) | $950.50K | (m) | 8.75× |
| 2026-03-31 | $28.15M | $3.10M | $27.33M | (m) | $245.10K | (m) | $852.37K | (m) | 9.09× |
| 2025-12-31 | $30.99M | $3.80M | $30.81M | (m) | $0.00 | (m) | $625.00K | (m) | 8.16× |
| 2025-09-30 | $32.92M | $3.34M | $32.56M | (m) | $0.00 | (m) | $745.96K | (m) | 9.86× |
| 2025-06-30 | $35.12M | $2.65M | $34.26M | (m) | $134.60K | (m) | $569.45K | (m) | 13.26× |
| 2025-03-31 | $37.68M | $2.13M | $36.57M | (m) | (m) | (m) | $718.89K | (m) | 17.66× |
| 2024-12-31 | $41.07M | $2.96M | $40.36M | (m) | (m) | (m) | $1.10M | (m) | 13.88× |
| 2024-09-30 | $43.27M | $2.60M | $42.28M | (m) | (m) | (m) | $708.20K | (m) | 16.66× |
| 2024-06-30 | $45.51M | $2.49M | $44.34M | (m) | (m) | (m) | $667.70K | (m) | 18.24× |
| 2024-03-31 | $47.86M | $2.51M | $47.14M | (m) | (m) | (m) | $804.76K | (m) | 19.07× |
| 2023-12-31 | $51.17M | $3.28M | $51.00M | (m) | (m) | (m) | $1.00M | (m) | 15.61× |
| 2023-09-30 | $53.00M | $2.80M | $51.51M | (m) | $1.00M | (m) | $736.90K | (m) | 18.92× |
| 2023-06-30 | $53.52M | $2.82M | $52.88M | (m) | (m) | (m) | $548.22K | (m) | 18.97× |
| 2023-03-31 | $56.03M | $2.72M | $55.26M | (m) | (m) | (m) | $585.07K | (m) | 20.64× |
| 2022-12-31 | $58.99M | $3.19M | $18.51M | (m) | (m) | (m) | $424.65K | (m) | 18.51× |
| 2022-09-30 | $53.15M | $4.53M | $52.51M | (m) | (m) | (m) | $552.72K | (m) | 11.74× |
| 2022-06-30 | $65.96M | $3.84M | $65.23M | (m) | (m) | (m) | $642.63K | (m) | 17.17× |
| 2022-03-31 | $68.83M | $2.98M | $67.70M | (m) | (m) | (m) | $665.25K | (m) | 23.13× |
| 2021-12-31 | $72.01M | $2.83M | $71.43M | (m) | (m) | (m) | $402.74K | (m) | 25.42× |
| 2021-09-30 | $76.16M | $4.20M | $75.03M | (m) | (m) | (m) | $642.42K | (m) | 18.12× |
| 2021-06-30 | $78.91M | $2.47M | $77.79M | (m) | (m) | (m) | $607.15K | (m) | 31.99× |
| 2021-03-31 | $81.47M | $1.83M | $76.30M | (m) | $4.00M | (m) | $428.15K | (m) | 44.49× |
| 2020-12-31 | $60.72M | $2.19M | $60.04M | (m) | (m) | (m) | $616.63K | (m) | 27.67× |
| 2020-09-30 | $62.56M | $1.80M | $61.66M | (m) | (m) | (m) | $376.27K | (m) | 34.67× |
| 2020-06-30 | $61.05M | $2.77M | $60.44M | (m) | (m) | (m) | $576.51K | (m) | 22.01× |
| 2020-03-31 | $62.17M | $1.79M | $61.33M | (m) | (m) | (m) | $377.50K | (m) | 34.64× |
| 2019-12-31 | $64.30M | $2.23M | $63.79M | (m) | (m) | (m) | $451.33K | (m) | 28.86× |
| 2019-09-30 | $63.27M | $1.73M | $62.87M | (m) | (m) | (m) | $230.38K | (m) | 36.50× |
| 2019-06-30 | $62.25M | $1.79M | $61.74M | (m) | (m) | (m) | $328.16K | (m) | 34.78× |
| 2019-03-31 | $63.76M | $1.37M | $63.21M | (m) | (m) | (m) | $254.11K | (m) | 46.40× |
| 2018-12-31 | $62.76M | $2.19M | $62.31M | (m) | (m) | (m) | $616.75K | (m) | 28.63× |
| 2018-09-30 | $62.81M | $1.80M | $62.44M | (m) | (m) | (m) | $608.28K | (m) | 34.81× |
| 2018-06-30 | $64.61M | $1.57M | $64.16M | (m) | (m) | (m) | $351.87K | (m) | 41.20× |
| 2018-03-31 | $63.57M | $1.20M | $62.94M | (m) | (m) | (m) | $361.41K | (m) | 53.02× |
| 2017-12-31 | $28.33M | $2.88M | $27.99M | (m) | (m) | (m) | $1.52M | (m) | 9.83× |
| 2017-09-30 | $25.01M | $1.74M | $24.54M | (m) | (m) | (m) | $301.71K | (m) | 14.39× |
| 2017-06-30 | $23.36M | $1.42M | $22.89M | (m) | (m) | (m) | $300.41K | (m) | 16.45× |
| 2017-03-31 | $22.32M | $1.02M | $21.64M | (m) | (m) | (m) | $158.14K | (m) | 21.84× |
| 2016-12-31 | $24.70M | $1.63M | $24.12M | (m) | (m) | (m) | $367.27K | (m) | 15.16× |
| 2016-09-30 | $25.61M | $1.38M | $24.97M | (m) | (m) | (m) | $265.58K | (m) | 18.63× |
| 2016-06-30 | $27.22M | $1.33M | $26.57M | (m) | (m) | (m) | $209.72K | (m) | 20.42× |
| 2016-03-31 | $28.69M | $1.05M | $27.62M | (m) | (m) | (m) | $77.12K | (m) | 27.33× |
| 2015-12-31 | $22.73M | $1.49M | $22.08M | (m) | (m) | (m) | $170.79K | (m) | 15.25× |
| 2015-09-30 | $24.34M | $1.30M | $23.61M | (m) | (m) | (m) | $354.70K | (m) | 18.78× |
| 2015-06-30 | $9.60M | $1.11M | $8.58M | (m) | (m) | (m) | $177.56K | (m) | 8.67× |
| 2015-03-31 | $10.34M | $853.03K | $9.07M | (m) | (m) | (m) | $110.38K | (m) | 12.12× |
| 2014-12-31 | $12.13M | $1.59M | $11.67M | (m) | (m) | (m) | $461.97K | (m) | 7.61× |
| 2014-09-30 | $12.63M | $1.13M | $11.94M | (m) | (m) | (m) | $317.69K | (m) | 11.13× |
| 2014-06-30 | $14.40M | $1.10M | $13.50M | (m) | (m) | (m) | $38.03K | (m) | 13.14× |
| 2014-03-31 | $16.06M | $901.82K | $14.78M | (m) | (m) | (m) | $153.87K | (m) | 17.81× |
| 2013-12-31 | $14.38M | $460.44K | $6.70M | (m) | (m) | (m) | $33.89K | (m) | 31.24× |
| 2013-09-30 | $11.04M | $1.10M | $10.66M | (m) | (m) | (m) | $186.89K | (m) | 10.04× |
| 2013-06-30 | $12.50M | $1.08M | $12.02M | (m) | (m) | (m) | $130.82K | (m) | 11.62× |
| 2013-03-31 | $3.71M | $948.15K | $3.03M | (m) | (m) | (m) | $269.86K | (m) | 3.92× |
| 2012-12-31 | $4.42M | $1.04M | $4.01M | (m) | (m) | (m) | $491.85K | (m) | 4.26× |
| 2012-09-30 | $6.34M | $1.16M | $5.74M | (m) | (m) | (m) | $333.00K | (m) | 5.49× |
| 2012-06-30 | $7.89M | $3.21M | $7.26M | (m) | (m) | (m) | $440.11K | (m) | 2.46× |
| 2012-03-31 | $11.80M | $2.74M | $11.01M | (m) | (m) | (m) | $309.42K | (m) | 4.31× |
| 2011-12-31 | $15.71M | $3.70M | $15.09M | (m) | (m) | (m) | $718.88K | (m) | 4.25× |
| 2011-09-30 | $9.56M | $3.43M | $8.74M | (m) | (m) | (m) | $1.08M | $0.00 | 2.79× |
| 2011-06-30 | $12.71M | $2.45M | $11.92M | (m) | (m) | (m) | $329.34K | $0.00 | 5.19× |
| 2010-12-31 | $58.34M | $36.79M | $28.25M | (m) | (m) | (m) | $1.10M | $4.95M | 1.59× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |